Unlicensed drugs worth Rs 1.20 crore seized in Patna

PATNA: Acting on a tip-off, the directorate of drugs control on Friday seized unlicensed medicines worth Rs1.20 crore from a shop-cum-godown in Narayan market on Govind Mitra Road, the hub of drug trade, in the state capital.

A seven-member team, led by Dr Sachchidanand Vikrant, assistant director, directorate of drugs control administration, raided the shop and seized drugs of various brands illegally stored for sale.
“It is illegal to trade such medicines without obtaining license from the government. All such medicines, including some common ones like paracetamol and cough syrups, were seized instantly,” said Vikrant. The details of seizure would be produced before a court for further legal action, he said.

Govind Mitra Road houses over 3,000 retail and wholesale shops and godowns of medicines, which are supplies all over the state.

Related Posts

  • Pharma
  • June 27, 2025
  • 46 views
Sun Pharma ropes in Richard Ascroft as North America CEO

Mumbai: Sun Pharma has announced the appointment of Richard Ascroft as the new North America (NAM) Chief Executive Officer (CEO). In a statement shared via LinkedIn, the company said, “We…

  • Pharma
  • June 27, 2025
  • 53 views
Torrent Pharma shares surge 4% as JPMorgan upgrades to overweight; 18% upside seen

Shares of Torrent Pharmaceuticals rose as much as 4 percent to Rs 3,350 on Friday after global brokerage JPMorgan upgraded the stock to ‘Overweight’, citing strong growth levers in the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Sun Pharma ropes in Richard Ascroft as North America CEO

Sun Pharma ropes in Richard Ascroft as North America CEO

Torrent Pharma shares surge 4% as JPMorgan upgrades to overweight; 18% upside seen

Torrent Pharma shares surge 4% as JPMorgan upgrades to overweight; 18% upside seen

Most Advanced Cancer Care is New Chapter @ Sir Ganga Ram

Most Advanced Cancer Care is New Chapter @ Sir Ganga Ram

Chemotherapy drugs made by Indian firms fail quality tests, shows study

Chemotherapy drugs made by Indian firms fail quality tests, shows study